(Q35019451)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470802%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

review article

1 reference

title

Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470802%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470802%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Glenda M Bishop

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470802%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470802%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

published in

Neurobiology of Aging

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470802%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470802%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

1051-1072

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470802%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470802%20AND%20SRC:MED&resulttype=core&format=json

Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex.

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Reduced cerebrospinal fluid levels of alpha-secretase-cleaved amyloid precursor protein in aged rats: correlation with spatial memory deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Ferritin as a source of iron and protection from iron-induced toxicities

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation. A clinical and genealogical investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Glial expression of the beta-amyloid precursor protein (APP) in global ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic-Cu/Zn superoxide dismutase neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Functional phenotype in transgenic mice expressing mutant human presenilin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study. Etude sur le Vieillissement Artériel.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Does human betaA4 exert a protective function against oxidative stress in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Implications for oxygen-free-radical-induced tissue destruction during ischaemia and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Enzymes of Leukocyte Oxidative Metabolism in Down's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Superoxide ion as a primary reductant in ascorbate-mediated ferritin iron release

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Rapid induction of Alzheimer A beta amyloid formation by zinc.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Neuron loss in APP transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Characterization of human presenilin 1 transgenic rats: increased sensitivity to apoptosis in primary neuronal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Pro-inflammatory complement activation by the A beta peptide of Alzheimer's disease is biologically significant and can be blocked by vaccinia virus complement control protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Alzheimer neuropathologic alterations in aged cognitively normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

An autopsy-verified study of the effect of education on degenerative dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Regenerative failure: a potential mechanism for neuritic dystrophy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Inhibition of neurite outgrowth by familial Alzheimer's disease-linked presenilin-1 mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Molecular basis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Impaired neurotransmitter uptake in PC12 cells overexpressing human Cu/Zn-superoxide dismutase--implication for gene dosage effects in Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

A portrait of Alzheimer secretases--new features and familiar faces

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Dystrophic neurites of senile plaques are defective in proteins involved in exocytosis and neurotransmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Heritability for Alzheimer's disease: the study of dementia in Swedish twins

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Overexpression of a calcium-binding protein, S100 beta, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Long-term changes in the aggregation state and toxic effects of beta-amyloid injected into the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Neuronal and glial gene expression in neocortex of Down's syndrome and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Distribution of beta-amyloid protein in the brain following severe head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Head circumference as a measure of cognitive reserve. Association with severity of impairment in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta 1 and interleukin-1 beta in astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Progress toward valid transgenic mouse models for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Proteolysis by presenilins and the renaissance of tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Alzheimer's disease: the amyloid cascade hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

A beta and perlecan in rat brain: glial activation, gradual clearance and limited neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Mutant and native human beta-amyloid precursor proteins in transgenic mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Involvement of amyloid precursor protein in memory formation in the rat: an indirect antibody approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Perforant pathway changes and the memory impairment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Expression of apolipoprotein E during nerve degeneration and regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Beta-amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Ferritin--a general metal detoxicant

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Brain samples from Alzheimer's patients have elevated levels of loosely bound iron.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's beta(25-35) amyloid fibril

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 4242, apolipoprotein E and transthyretin in human cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Beta-amyloid precursor protein isoforms in various rat brain regions and during brain development

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Copper, iron and zinc in Alzheimer's disease senile plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

APOE epsilon4 allele and amyloid beta-protein deposition in long term survivors of head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The topography of plaques and tangles in Down's syndrome patients of different ages

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Familial Alzheimer's disease-linked mutations at Val717 of amyloid precursor protein are specific for the increased secretion of A beta 42(43).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Altered expression of amyloid precursors proteins after traumatic brain injury in rats: in situ hybridization and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The neurotoxicity of amyloid beta protein in aged primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Is beta-APP a marker of axonal damage in short-surviving head injury?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Congenital Disorders of the Functions of Polymorphonuclear Neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Amyloid load and neural elements in Alzheimer's disease and nondemented individuals with high amyloid plaque density.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Involvement of amyloid precursor protein in functional synapse formation in cultured hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Cortical cholinergic dysfunction after human head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Histopathological studies of senile plaques and cerebral amyloidosis in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Alzheimer's disease in 22 twin pairs--13-year follow-up: hormonal, infectious and traumatic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Alzheimer's disease: a dysfunction of the amyloid precursor protein(1).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Alzheimer's disease: a re-examination of the amyloid hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Extracellular space structure revealed by diffusion analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Oxidative damage is the earliest event in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Early glycoxidation damage in brains from Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Soluble derivatives of the beta amyloid protein precursor of Alzheimer's disease are labeled by antisera to the beta amyloid protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The effects of excitotoxicity on the expression of the amyloid precursor protein gene in the brain and its modulation by neuroprotective agents

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Isoform-specific vasoconstriction induced by apolipoprotein E and modulation of this effect by Alzheimer's beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Neuroimaging findings in twins discordant for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Neurobiological bases of age-related cognitive decline in the rhesus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

New protease inhibitors prevent gamma-secretase-mediated production of Abeta40/42 without affecting Notch cleavage

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Recent advances in the genetics of Alzheimer's disease and vascular dementia with an emphasis on gene-environment interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Ischemic rats as a model in the study of the neurobiological role of human beta-amyloid peptide. Time-dependent disappearing diffuse amyloid plaques in brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

ApoE genotype and Alzheimer's disease in adults with Down syndrome: meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E and cognitive performance

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Alzheimer's disease in Finnish twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The role of amyloid beta-protein in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Genetic susceptibility factors for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Redox-active iron mediates amyloid-beta toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Suicide and Alzheimer's pathology in the elderly: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The role of iron in beta amyloid toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Evidence for apoptosis in the fetal Down syndrome brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Skeletal and CNS defects in Presenilin-1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Hypoglycemia enhances the expression of mRNA encoding beta-amyloid precursor protein in rat primary cortical astroglial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Amyloid beta-protein deposition in the leptomeninges and cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Lack of correlation between plaque burden and cognition in the aged monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Arson. Tracking the culprit in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Linguistic ability in early life and the neuropathology of Alzheimer's disease and cerebrovascular disease. Findings from the Nun Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Increased levels of the Kunitz protease inhibitor-containing beta APP mRNAs in rat brain following neurotoxic damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

ApoE as a prognostic factor for post–traumatic coma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Genetic factors in the genesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

In vitro evidence that beta-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Learning deficits in aged rats related to decrease in extracellular volume and loss of diffusion anisotropy in hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Diffusion constraints and neuron-glia interaction during aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Impaired neurotransmitter systems by Abeta amyloidosis in APPsw transgenic mice overexpressing amyloid beta protein precursor.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

New evidence that the Alzheimer beta-amyloid peptide does not spontaneously form free radicals: an ESR study using a series of spin-traps.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Binding partners of Alzheimer's disease proteins: are they physiologically relevant?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Reorganization of cingulate cortex in Alzheimer's disease: neuron loss, neuritic plaques, and muscarinic receptor binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Amyloid precursor protein and membrane phospholipids in primary cortical neurons increase with development, or after exposure to nerve growth factor or Abeta(1-40)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

The CA1 region of the human hippocampus is a hot spot in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Beta-amyloid precursor protein (APP) and APP-RNA are rapidly affected by glutamate in cultured neurons: selective increase of mRNAs encoding a Kunitz protease inhibitor domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Learning and memory in S100-beta transgenic mice: an analysis of impaired and preserved function.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Deposits of A beta fibrils are not toxic to cortical and hippocampal neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Beta-secretase processing of the beta-amyloid precursor protein in transgenic mice is efficient in neurons but inefficient in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Mice deficient for the amyloid precursor protein gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Presenilin-1 polymorphism and amyloid beta-protein deposition in fatal head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900342-6

7 January 2021

10.1016/S0197-4580(01)00342-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470802%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference